The novel targeting system, PTK7-GEMs, was established based on a biomarker (PTK7) in BC and through phosphodiester bond integrating three molecules of GEM onto one molecule of PTK7 aptamer, achieving high loading of anticancer drugs, and providing a scientific and reliable strategy to achieve better delivery capacity. This evidence concerns the gene PTK7 and breast cancer.